Zhitong Finance App News, Shandong Xinhua Pharmaceutical Co., Ltd. (00719) issued an announcement. The Company's executive director, Mr. He Tongqing (Mr. He), resigned on November 10, 2026 due to job changes (this resignation) as Chairman of the Company, executive director, members of various special committees under the Board of Directors, authorized representatives of the Company (in accordance with section 3.05 of the Listing Rules), and all positions of the company's subsidiaries. The resignation took effect on November 10, 2026. Since then, Mr. He has ceased to hold any directorial or senior management positions and positions with the Company or its subsidiaries.
Approved by the Board of Directors resolution after the Extraordinary Shareholders' Meeting, Mr. Liu Weimin (Mr. Liu) has been elected as Chairman of the 11th Board of Directors. The term of office begins on the day the shareholders approve it at the EGM (i.e. November 10, 2026) and ends on December 21, 2026, when the term of the 11th board of directors expires.
Based on this resignation, Mr. He is no longer an authorized representative (authorized representative) of the Company, effective November 10, 2026. Approved by the Board of Directors resolution after the Extraordinary Shareholders' Meeting, Mr. Liu has been elected as an authorized representative with effect from November 10, 2026. The Company continues to have two authorized representatives, Mr. Liu Weimin and Mr. Cao Changqiu, and will continue to comply with Rule 3.05 of the Listing Rules.
Following his resignation, Mr. He no longer served as the chairman of the Strategic Development Committee (Strategic Development Committee) of the Company's board of directors and a member of the Nomination Committee (Nomination Committee) of the Board of Directors of the Company, effective from the end of the Extraordinary Shareholders' Meeting. Following the appointment of Mr. Liu as an executive director, the board of directors has resolved to appoint Mr. Liu as the chairman of the Strategic Development Committee and a member of the Nomination Committee.